跳至主要内容
临床试验/NCT02690532
NCT02690532已完成不适用

The Role of Gut Permeability in Developing Celiac Disease and Non-Celiac Gluten Sensitivity

Mayo Clinic1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2016年3月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Mayo Clinic
入组人数
40
试验地点
1
主要终点
Gut Permeability

研究概览

简要总结

This study will assess the effect of gluten on gut barrier function. Investigators at the Mayo Clinic have developed a new gut permeability test using rhamnose (sugar & water solution), and are hoping to prove its effectiveness in a clinical setting.

详细描述

The aim of this study is to assess effect of gluten on the gut barrier function in patients at high risk for celiac disease and non-celiac gluten sensitivity (NCGS) patients. This study will assess the gut permeability in three groups of patients 1) children who are at high risk for developing celiac disease (CD) (siblings of patients with celiac disease), 2) Children who are self-diagnosed with NCGS and 3) control group of patients matched for age and gender. Patients will undergo celiac serologic and genetic testing, after which the rhamnose test will be performed to assess the presence of increased gut permeability.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
2 Years 至 17 Years(Child)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Gut Permeability

时间窗: Baseline

Assess the effect of gluten on gut permeability in children at high risk of developing celiac disease or gluten sensitivity

次要结局

未报告次要终点

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Imad Absah

M.D., Assistant Professor of Pediatrics

Mayo Clinic

研究点 (1)

Loading locations...

相似试验